XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

Income tax benefit consists of the following:

 

Year Ended December 31

  2020     2019  
Current taxes - Federal   $ (233,000 )   $ -  
Current taxes - State     42,000       38,000  
Deferred taxes - Federal     -       (437,000 )
Deferred taxes - State     -       (67,000 )
                 
Income tax benefit   $ (191,000 )   $ (466,000 )

 

The actual tax benefit attributable to loss before taxes differs from the expected tax benefit computed by applying the U.S. federal corporate income tax rate of 21% as follows:

 

Year Ended December 31

  2020     2019  
Federal statutory rate     21.0 %     21.0 %
                 
Stock-based awards     (0.8 )     (0.8 )
State taxes     3.5       3.2  
Other permanent differences     -       (0.1 )
Impact of uncertain tax positions     (0.7 )     (0.6 )
Valuation allowance     (19.5 )     (14.0 )
Other     0.8       (0.2 )
                 
Effective federal income tax rate     4.3 %     8.5 %

 

Components of resulting noncurrent deferred tax assets (liabilities) are as follows:

 

As of December 31

  2020     2019  
Deferred tax assets            
Accrued expenses   $ 153,000     $ 105,000  
Inventory reserve     9,000       5,000  
Stock-based awards     65,000       88,000  
Reserve for bad debts     33,000       16,000  
Net operating loss and credit carryforwards     1,422,000       715,000  
Other     47,000       26,000  
Depreciation     52,000       -  
Valuation allowance     (1,723,000 )     (848,000 )
                 
Total deferred tax assets   $ 58,000     $ 107,000  
                 
Deferred tax liabilities                
Depreciation   $ -     $ (18,000 )
Prepaid expenses     (58,000 )     (89,000 )
                 
Total deferred tax liabilities     (58,000 )     (107,000 )
                 
Net deferred income tax liabilities   $ -     $ -  

 

As of December 31, 2020, the Company had a Federal net operating loss (NOL) to carry forward of approximately $5,400,000 and state NOLs of approximately $4,500,000 to carry forward. The Federal NOLs can be carried forward indefinitely. The expiration of state NOLs carried forward varies by taxing jurisdiction.

 

Section 382 of the U.S. Internal Revenue Code of 1986 (“Section 382”), as amended, generally imposes an annual limitation on the amount of NOL carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. During 2020, we believe we may have experienced an ownership change as defined in Section 382 which would limit our ability to utilize our NOLs. The Company has not yet completed a formal Section 382 analysis. In addition, our ability to utilize the current NOL carryforwards might be further limited by future issuances of our common stock.

 

In March 2020, Congress passed the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The CARES Act, among other provisions, allows for companies to carry back federal NOLs generated in 2018, 2019 and 2020 for up to five years for refunds of federal taxes paid. This provision created an opportunity for the Company to utilize NOLs not previously expected to be utilized. Thus, the Company has reversed approximately $215,000 of its valuation allowance against the NOLs in its deferred tax assets which the Company carried back to claim a refund of federal taxes paid. As the Company expects to receive the tax refund from the ability to carry back the NOLs within the next 12 months, this discrete benefit has been recorded within income taxes receivable on the balance sheet. In addition to the $215,000 recognized, $17,000 was included as a discrete tax benefit for the year and included in income taxes receivable related to the NOL carry back due to differences in the federal tax rate utilized for the deferred tax asset compared to the rates in effect for the years in which the NOL is being carried back.

 

The Company evaluates all significant available positive and negative evidence, including the existence of losses in prior years and its forecast of future taxable income, in assessing the need for a valuation allowance. The underlying assumptions the Company uses in forecasting future taxable income require significant judgment and take into consideration the Company’s recent performance. The change in the valuation allowance for the years ended December 31, 2020 and 2019 was $875,000 and $769,000, respectively.

 

The Company has recorded a liability of $677,000 and $643,000 for uncertain tax positions taken in tax returns in previous years as of December 31, 2020 and 2019, respectively. This liability is reflected as accrued income taxes on the Company’s balance sheets. The Company files income tax returns in the United States and numerous state and local tax jurisdictions. Tax years 2017 and forward are open for examination and assessment by the Internal Revenue Service. With limited exceptions, tax years prior to 2017 are no longer open in major state and local tax jurisdictions. The Company does not anticipate that the total unrecognized tax benefits will change significantly prior to December 31, 2021.

 

A reconciliation of the beginning and ending amount of the liability for uncertain tax positions is as follows:

 

Balance at January 1, 2019   $ 613,000  
Increases due to interest and state tax     30,000  
Balance at December 31, 2019     643,000  
Increases due to interest and state tax     34,000  
Balance at December 31, 2020   $ 677,000